Utah Patent of the Month – January 2024

In the ever-evolving landscape of viral containment, a new approach by SINTX Technologies, Inc. is taking center stage. With the ongoing global challenges posed by viruses like SARS-CoV-2, the need for effective, long-lasting antiviral solutions has never been more critical.

SINTX’s inventive method revolves around the strategic use of silicon nitride powder, a material known for its exceptional properties, ranging from strength to biocompatibility. The method provides a comprehensive approach to inactivating human viruses, presenting a game-changing advancement in the realm of antiviral technology.

The core of the invention lies in the meticulous composition of the silicon nitride powder, finely tuned to a concentration between 1 wt. % and 30 wt. %. The powder’s average particle size, ranging from 0.6 μm to 5 μm, plays a crucial role in its efficacy. When integrated into or coated onto various surfaces, such as protective gowns, masks, or even furniture like handles and rails, the silicon nitride engages in a dual-action process.

Upon contact with the virus, the silicon nitride successively binds to it, creating a powerful interaction that sets the stage for the second phase—inactivation. The inventive method showcases remarkable results, achieving an inactivation rate of at least 99%, a testament to its efficacy against a wide array of human viruses, excluding SARS-CoV-2.

What makes this invention even more versatile is its adaptability to different materials. Objects incorporating this method can be made of paper, cardboard, fabric, plastic, ceramic, stainless steel, metal, or a combination thereof. This flexibility expands the potential applications of the invention across various industries, from healthcare to everyday items.

Notably, the SINTX invention introduces a safe and practical solution for viral inactivation. Unlike traditional methods relying on chemical applications or UV irradiation, the silicon nitride-based approach minimizes toxicity concerns, making it a promising option for widespread use.

As the world continues its battle against viral threats, SINTX Technologies emerges as a pioneer, providing a revolutionary invention that not only captures attention in the field of research and development but also holds the promise of transforming how we approach viral containment in our daily lives.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Recent Posts